Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-470,126
Closed -$19.9M 173
2024
Q2
$19.9M Buy
470,126
+23,528
+5% +$1.03M 1.64% 12
2024
Q1
$19.7M Sell
446,598
-42,509
-9% -$1.94M 1.76% 15
2023
Q4
$22.5M Buy
489,107
+47,414
+11% +$2.02M 2.82% 5
2023
Q3
$19M Buy
+441,693
New +$20.6M 1.16% 7

Other funds holding QGEN

Point72 Europe's QGEN Position: Q3 2024 in Review

Point72 Europe sold out of Qiagen (QGEN) in Q3 2024, closing a stake of 470,126 shares — an estimated $19.9M sold.

Point72 Europe first reported a position in QGEN in Q3 2023 and held it in 4 quarters. The position peaked at $22.5M in Q4 2023. 329 funds tracked by Wall St. Rank hold QGEN as of Q3 2024.

  • Point72 Europe reported no remaining Qiagen position as of Q3 2024 after selling out during the quarter.
  • Point72 Europe sold 470,126 Qiagen shares in Q3 2024, an estimated $19.9M.
  • Point72 Europe first reported a position in Qiagen in Q3 2023 and held it in 4 quarters.
  • Point72 Europe's Qiagen position peaked at $22.5M in Q4 2023.
  • 329 funds tracked by Wall St. Rank held Qiagen as of Q3 2024.

Based on Point72 Europe's 13F filing for Q3 2024, filed 14 Nov 2024.